IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $857,354 | -5.8% | 54,024 | +12.0% | 0.01% | 0.0% |
| Q2 2023 | $909,882 | +3539.5% | 48,218 | +370.0% | 0.01% | +1000.0% |
| Q3 2019 | $25,000 | -73.7% | 10,259 | -76.5% | 0.00% | -50.0% |
| Q2 2019 | $95,000 | +239.3% | 43,624 | +329.9% | 0.00% | +100.0% |
| Q1 2019 | $28,000 | -48.1% | 10,148 | -10.4% | 0.00% | 0.0% |
| Q4 2018 | $54,000 | -58.8% | 11,328 | -18.0% | 0.00% | -66.7% |
| Q3 2018 | $131,000 | +4.0% | 13,814 | -29.5% | 0.00% | 0.0% |
| Q4 2017 | $126,000 | -24.6% | 19,594 | -10.0% | 0.00% | -25.0% |
| Q3 2017 | $167,000 | +406.1% | 21,774 | +79.5% | 0.00% | +300.0% |
| Q3 2016 | $33,000 | -10.8% | 12,130 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $37,000 | -64.4% | 12,130 | -1.0% | 0.00% | -66.7% |
| Q1 2016 | $104,000 | – | 12,255 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |